Markets log worst week in 30 months

The benchmark indices fell 1.5% on Friday, marking their fifth consecutive day of decline in line with global peers and worst weekly loss since June 2022, as foreign investors shifted to safe-haven dollar assets.

The Sensex lost 1,176.46 points or 1.49% to close at 78,041.59, while the NSE Nifty declined 364.20 points or 1.52% to 23,587.50. The Nifty falls below its 200-day moving average for the first time in a month.

Also ReadCarraro India says India a long-term bet, see big opportunity in current market condition

While the Sensex plunged 4,091.53 points or 4.98% in the week, the Nifty slumped 1,180.80 points or 4.77%. The sell-off comes after four consecutive weeks of positive returns.

On Friday, broader markets saw a heightened selling pressure, with the BSE Midcap and BSE Smallcap indices falling 2.43% and 2.11%, respectively, compared to the benchmarks’ 1.5% decline. On a weekly basis, however, the broader indices posted smaller losses of around 3.2% each.

“Nervousness continued to grip investors, leading to a broad-based selling, as the dollar’s ongoing strength against the rupee prompted foreign investors to exit local equities and seek safety in dollar assets,” said Prashanth Tapse, senior VP (Research) at Mehta Equities.

Investor sentiment was also dampened by concerns over Donald Trump’s trade policies, as his aggressive stance could potentially disrupt global markets when he assumes office in mid-January next year, Tapse added.

Barring healthcare, which gained 0.10%, all sectoral indices ended the week in the red. Power, metal, utilities, capital goods and PSU banks fell more than 6% each, while the Bank Nifty dropped 2,825 points or 5.27%.

Among individual stocks, all 30 Sensex constituents posted negative returns for the week. Out of the 50 Nifty stocks, only Dr Reddy’s Laboratories (up 7.81%) and Cipla (up 1.71%) managed to stay in positive territory.

Top losers include Shriram Finance, Tata Motors, JSW Steel, Bharat Electronics, Grasim Industries and Adani Enterprises with a fall of over 7%.

Also ReadAdani Enterprises shares down 1%; favourable ruling in Dharavi redevelopment case fails to cheer up stock

Broad-based selling wiped out Rs 18.43 lakh crore of investor wealth during the week, with half of the losses occurring on Friday.

Foreign portfolio investors (FPIs) net sold shares worth Rs 3,598 crore on Friday and Rs 7,510 crore over the week.

 » Read More

Related Articles

Q3FY25 Results: Thyrocare reports 30 percent rise in profit; Revenue stood at Rs 165.9 Crore

Thyrocare on Thursday announced its financial results for the quarter and nine months ended December 31, 2024. According to the company’s statement, the diagnostics major reported revenue of Rs. 165.9 Cr in Q3FY25 with a growth of 23 percent YoY. According to the company’s statement, Thyrocare’s consolidated revenue increased by 23% year-over-year (YoY) with Pathology

Gold prices soar to new peak of Rs 82,900 per 10 gm; silver drops by Rs 500

Gold prices rose Rs 170 to hit a fresh record high of Rs 82,900 per 10 grams in the national capital on Thursday amid a positive global trend, according to the All India Sarafa Association. The precious metal had closed at Rs 82,730 per 10 grams on Wednesday. In about one year, the precious metal

Good news for taxpayers! Govt removes THESE difficulties to ensure more tax cases are settled – Check details!

Good news for taxpayers! The Finance Ministry has made some changes to the Direct Tax Vivad Se Vishwas Scheme, 2024, removing “difficulties” that arose due to certain situations for taxpayers. This update in the scheme will bring relief to taxpayers who wanted to apply for the scheme but could not do so earlier. “CBDT…makes the

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

Q3FY25 Results: Thyrocare reports 30 percent rise in profit; Revenue stood at Rs 165.9 Crore

Thyrocare on Thursday announced its financial results for the quarter and nine months ended December 31, 2024. According to the company’s statement, the diagnostics major reported revenue of Rs. 165.9 Cr in Q3FY25 with a growth of 23 percent YoY. According to the company’s statement, Thyrocare’s consolidated revenue increased by 23% year-over-year (YoY) with Pathology

Gold prices soar to new peak of Rs 82,900 per 10 gm; silver drops by Rs 500

Gold prices rose Rs 170 to hit a fresh record high of Rs 82,900 per 10 grams in the national capital on Thursday amid a positive global trend, according to the All India Sarafa Association. The precious metal had closed at Rs 82,730 per 10 grams on Wednesday. In about one year, the precious metal

Good news for taxpayers! Govt removes THESE difficulties to ensure more tax cases are settled – Check details!

Good news for taxpayers! The Finance Ministry has made some changes to the Direct Tax Vivad Se Vishwas Scheme, 2024, removing “difficulties” that arose due to certain situations for taxpayers. This update in the scheme will bring relief to taxpayers who wanted to apply for the scheme but could not do so earlier. “CBDT…makes the

Johnnie Walker-maker United Spirits posts Q3 profit decline of 4.29% to Rs 335 crore, revenue up 11.06% YoY

United Spirits, which makes Smirnoff vodka, on Thursday reported a profit of Rs 335 crore for the third quarter of FY25, posting a decline of 4.29 per cent in comparison to Rs 350 crore during the corresponding quarter of previous financial year. It posted revenue from operations at Rs 7,732 crore, reporting a growth of

Q3FY25: Mankind Pharma’s revenue up by 24 percent to Rs 3,230 Crore; Profit at Rs 380 crore

Pharma major Mankind Pharma on Thursday reported its financial results for the third quarter and nine months ended 31 st December 2024. The company reported revenue from Operations at Rs. 3,230 Cr, up by 24% YoY and domestic revenue at INR 2,773 Cr, up 17%, Exports at INR 457 Cr, up 121% YoY. The company’s